GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (HKSE:06618) » Definitions » Debt-to-EBITDA
中文

JD Health International (HKSE:06618) Debt-to-EBITDA : 0.12 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is JD Health International Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

JD Health International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$104 Mil. JD Health International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$131 Mil. JD Health International's annualized EBITDA for the quarter that ended in Dec. 2023 was HK$1,897 Mil. JD Health International's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.12.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for JD Health International's Debt-to-EBITDA or its related term are showing as below:

HKSE:06618' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.24   Med: 0.01   Max: 0.24
Current: 0.08

During the past 7 years, the highest Debt-to-EBITDA Ratio of JD Health International was 0.24. The lowest was -0.24. And the median was 0.01.

HKSE:06618's Debt-to-EBITDA is ranked better than
93.32% of 419 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs HKSE:06618: 0.08

JD Health International Debt-to-EBITDA Historical Data

The historical data trend for JD Health International's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JD Health International Debt-to-EBITDA Chart

JD Health International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial -0.01 -0.01 -0.24 0.24 0.08

JD Health International Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.18 0.25 0.31 0.06 0.12

Competitive Comparison of JD Health International's Debt-to-EBITDA

For the Medical Care Facilities subindustry, JD Health International's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JD Health International's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where JD Health International's Debt-to-EBITDA falls into.



JD Health International Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

JD Health International's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(104.262 + 130.631) / 2956.302
=0.08

JD Health International's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(104.262 + 130.631) / 1897.094
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


JD Health International  (HKSE:06618) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


JD Health International Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of JD Health International's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


JD Health International (HKSE:06618) Business Description

Traded in Other Exchanges
Address
No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.

JD Health International (HKSE:06618) Headlines

No Headlines